ArticleThe Journal of urology2020
Erratum: Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.
No numbers read from the abstract.